Margaret E Smith1, Daniel Bacal2, Aaron J Bonham3, Oliver A Varban3, Arthur M Carlin4, Amir A Ghaferi3, Jonathan F Finks3. 1. Department of General Surgery, University of Michigan, Ann Arbor, Michigan. Electronic address: smargare@med.umich.edu. 2. Department of Surgery, Beaumont Hospital Dearborn, Dearborn, Michigan. 3. Department of General Surgery, University of Michigan, Ann Arbor, Michigan. 4. Department of Surgery, Henry Ford Health System, Detroit, Michigan.
Abstract
BACKGROUND: Although bariatric surgery is an effective treatment for obesity, utilization of bariatric procedures in older adults remains low. Previous work reported higher morbidity in older patients undergoing bariatric surgery. However, the generalizability of these data to contemporary septuagenarians is unclear. OBJECTIVES: We sought to evaluate differences in 30-day outcomes, 1-year weight loss, and co-morbidity remission after bariatric surgery among 3 age groups as follows: <45 years, 45-69 years, and ≥70 years. SETTING: Statewide quality improvement collaborative. METHODS: Using a large quality improvement collaborative, we identified patients undergoing sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2006 and 2018. We used multivariable logistic regression models to evaluate the association between age cohorts and 30-day outcomes, 1-year weight loss, and co-morbidity remission. RESULTS: We identified 641 septuagenarians who underwent SG (68.5%) or RYGB (31.5%). Compared with 45-69 year olds, septuagenarians had higher rates of hemorrhage (5.1% versus 3.1%; P = .045) after RYGB and higher rates of leak/perforation (.9% versus .3%; P = .044) after SG. Compared with younger patients, septuagenarians lost less of their excess weight, losing 64.8% after RYGB and 53.8% after SG. Remission rates for diabetes and obstructive sleep were similar for patients aged ≥70 years and 45-69 years. CONCLUSIONS: Bariatric surgery in septuagenarians results in substantial weight loss and co-morbidity remission with an acceptable safety profile. Surgeons with self-imposed age limits should consider broadening their selection criteria to include patients ≥70 years old.
BACKGROUND: Although bariatric surgery is an effective treatment for obesity, utilization of bariatric procedures in older adults remains low. Previous work reported higher morbidity in older patients undergoing bariatric surgery. However, the generalizability of these data to contemporary septuagenarians is unclear. OBJECTIVES: We sought to evaluate differences in 30-day outcomes, 1-year weight loss, and co-morbidity remission after bariatric surgery among 3 age groups as follows: <45 years, 45-69 years, and ≥70 years. SETTING: Statewide quality improvement collaborative. METHODS: Using a large quality improvement collaborative, we identified patients undergoing sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2006 and 2018. We used multivariable logistic regression models to evaluate the association between age cohorts and 30-day outcomes, 1-year weight loss, and co-morbidity remission. RESULTS: We identified 641 septuagenarians who underwent SG (68.5%) or RYGB (31.5%). Compared with 45-69 year olds, septuagenarians had higher rates of hemorrhage (5.1% versus 3.1%; P = .045) after RYGB and higher rates of leak/perforation (.9% versus .3%; P = .044) after SG. Compared with younger patients, septuagenarians lost less of their excess weight, losing 64.8% after RYGB and 53.8% after SG. Remission rates for diabetes and obstructive sleep were similar for patients aged ≥70 years and 45-69 years. CONCLUSIONS: Bariatric surgery in septuagenarians results in substantial weight loss and co-morbidity remission with an acceptable safety profile. Surgeons with self-imposed age limits should consider broadening their selection criteria to include patients ≥70 years old.
Authors: Edward H Livingston; Sergio Huerta; Denice Arthur; Scott Lee; Scott De Shields; David Heber Journal: Ann Surg Date: 2002-11 Impact factor: 12.969
Authors: Nancy J O Birkmeyer; Justin B Dimick; David Share; Abdelkader Hawasli; Wayne J English; Jeffrey Genaw; Jonathan F Finks; Arthur M Carlin; John D Birkmeyer Journal: JAMA Date: 2010-07-28 Impact factor: 56.272
Authors: Alexandra Chow; Noah J Switzer; Richdeep S Gill; Jerry Dang; Yi Man Ko; Xinzhe Shi; Daniel W Birch; Christopher de Gara; Shahzeer Karmali Journal: Obes Surg Date: 2016-03 Impact factor: 4.129
Authors: Wendy C King; Jia-Yuh Chen; Steven H Belle; Anita P Courcoulas; Gregory F Dakin; Katherine A Elder; David R Flum; Marcelo W Hinojosa; James E Mitchell; Walter J Pories; Bruce M Wolfe; Susan Z Yanovski Journal: JAMA Date: 2016-04-05 Impact factor: 56.272
Authors: Christopher P Scally; Oliver A Varban; Arthur M Carlin; John D Birkmeyer; Justin B Dimick Journal: JAMA Surg Date: 2016-06-15 Impact factor: 14.766
Authors: Hinali Zaveri; Amit Surve; Daniel Cottam; Christina Summerhays; Austin Cottam; Christina Richards; LeGrand Belnap; Walter Medlin Journal: Springerplus Date: 2016-10-07
Authors: Hugo Meunier; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Yoann Marion; Antoine Vallois; Nicolas Contival; Thomas Gautier; Jean Lubrano; Anaïs Briant; Jean-Jacques Parienti; Arnaud Alves Journal: Obes Surg Date: 2021-04-28 Impact factor: 4.129
Authors: Sophie L van Veldhuisen; Gijs van Woerden; Martin E W Hemels; Yves G C J America; Rudolf A de Boer; Michiel Rienstra; Dirk J van Veldhuisen; Eric J Hazebroek Journal: Surg Obes Relat Dis Date: 2020-09-02 Impact factor: 4.734